Pancreatic cancer, already the third-leading cause of cancer death in the U.S., stands out for its grim survival statistics, with a five-year survival rate of just 13%. Unlike many other cancers, death rates for pancreatic cancer have shown little improvement over time, leaving researchers and patients alike grappling with stagnant progress. The disease’s aggressive nature and late-stage diagnoses contribute to its devastating impact, underscoring an urgent need for better detection and treatment breakthroughs. New developments in early screening or targeted therapies could offer hope where progress has long stalled.
The third-leading cause of cancer death in the US, pancreatic cancer has one of the lowest survival rates of any major cancer. The five-year relative survival rate is just 13% and death rates have remained largely unchanged for years.
